Addison Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Addison Advisors's PFE Position: Q2 2026 in Review
Addison Advisors reduced its Pfizer (PFE) stake by 95% in Q2 2026, selling an estimated $884K and leaving 1,801 shares worth $43.4K. The position accounts for 0.02% of the portfolio, ranked #262.
Addison Advisors first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.51M in Q3 2024. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Addison Advisors held 1,801 shares of Pfizer worth $43.4K as of Q2 2026.
- Addison Advisors sold 33,801 Pfizer shares in Q2 2026, an estimated $884K.
- Pfizer made up 0.02% of Addison Advisors's portfolio in Q2 2026, its #262 holding.
- Addison Advisors first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
- Addison Advisors's Pfizer position peaked at $1.51M in Q3 2024.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.